BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 5319798)

  • 21. PENTAZOCINE. STRONG ANALGESICS AND ANALGESIC ANTAGONISTS IN THE BENZOMORPHAN SERIES.
    ARCHER S; ALBERTSON NF; HARRIS LS; PIERSON AK; BIRD JG
    J Med Chem; 1964 Mar; 7():123-7. PubMed ID: 14187360
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on 2-benzimidazolethiol derivatives. II. Synthesis and analgesic effects of 1-[2-(tert-amino)ethyl]-2-(arylthio)benzimidazole].
    Seki T; Sasazima M; Watanabe Y
    Yakugaku Zasshi; 1965 Nov; 85(11):962-70. PubMed ID: 5893836
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on analgesics of aniline series. II. Preparation and properties of N-alkyl or N,N-dialkyl 3-(N'-acyl-or N'-benzyl-substituted anilino)propionamide series and N-alkyl or N,N-dialkyl 3-(substituted anilino)propylamine series.
    Takamura K; Shioya A; Minamoto K; Yamamoto T; Yoshimitsu A; Nitta Y
    Chem Pharm Bull (Tokyo); 1965 Feb; 13(2):205-10. PubMed ID: 5863465
    [No Abstract]   [Full Text] [Related]  

  • 24. [Basically substituted 4-acylaminophenazones: synthesis and pharmacological effect].
    Mühle H; Ernst L; Meier W; Renker H
    Arzneimittelforschung; 1968 Jul; 18(7):850-4. PubMed ID: 5755832
    [No Abstract]   [Full Text] [Related]  

  • 25. Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
    Carter DS; Alam M; Cai H; Dillon MP; Ford AP; Gever JR; Jahangir A; Lin C; Moore AG; Wagner PJ; Zhai Y
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1628-31. PubMed ID: 19231180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of sodium 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarboxylate (GSK269984A) an EP(1) receptor antagonist for the treatment of inflammatory pain.
    Hall A; Billinton A; Brown SH; Chowdhury A; Clayton NM; Giblin GM; Gibson M; Goldsmith PA; Hurst DN; Naylor A; Peet CF; Scoccitti T; Wilson AW; Winchester W
    Bioorg Med Chem Lett; 2009 May; 19(9):2599-603. PubMed ID: 19332369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STRUCTURE-ACTIVITY REQUIREMENTS IN SOME NOVEL THEBAINE-DERIVED ANALGESICS.
    LISTER RE
    J Pharm Pharmacol; 1964 May; 16():364-6. PubMed ID: 14195685
    [No Abstract]   [Full Text] [Related]  

  • 28. [On some derivatives of 1-amino-adamantane].
    Tsatsas G; Costakis E; Casadio S; Lumachi B; Marazzi-Uberti E
    Ann Pharm Fr; 1969 May; 27(5):363-9. PubMed ID: 5400824
    [No Abstract]   [Full Text] [Related]  

  • 29. N-substituted dibenzoxazepines as analgesic PGE2 antagonists.
    Hallinan EA; Hagen TJ; Husa RK; Tsymbalov S; Rao SN; vanHoeck JP; Rafferty MF; Stapelfeld A; Savage MA; Reichman M
    J Med Chem; 1993 Oct; 36(22):3293-9. PubMed ID: 7901416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug latentiation. 3. Labile amide derivatives of normeperidine.
    Kupchan SM; Isenberg AC
    J Med Chem; 1967 Sep; 10(5):960-1. PubMed ID: 6048511
    [No Abstract]   [Full Text] [Related]  

  • 31. Analgesics 4. Studies on the effects of the introduction of methyl at C-17 of N-cyclopropylmethyl-normorphine: synthesis, receptor binding, in vivo activity, conformation energies.
    Lawson JA; Toll L; Loew GH; Frenking G; DeGraw JI; Uyeno ET; Polgar W; Camerman N; Camerman A; Adhikesavalu D
    NIDA Res Monogr; 1987; 76():309-15. PubMed ID: 2830525
    [No Abstract]   [Full Text] [Related]  

  • 32. [SOME ASPECTS OF THE PHARMACODYNAMIC ACTIVITY OF 3,5-DIMETHOXY-4-HYDROXYBENZOIC ACID DERIVATIVES].
    VACHER J; DUCHENNE-MARULAZ P; LAKATOS C; FARENC MJ; BUSCH N
    Med Pharmacol Exp Int J Exp Med; 1965; 12():49-55. PubMed ID: 14281477
    [No Abstract]   [Full Text] [Related]  

  • 33. Narcotic analgesics and antagonists.
    Lewis JW; Bentley KW; Cowan A
    Annu Rev Pharmacol; 1971; 11():241-70. PubMed ID: 4948499
    [No Abstract]   [Full Text] [Related]  

  • 34. [Structure-activity correlates, using regression analysis in the series of morphine-like analgesics].
    Kutter E; Herz A; Teschemacher HJ; Hess R
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):386-7. PubMed ID: 4253818
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmaceutical chemistry of major analgesics].
    Szász G; Takácsné NK
    Acta Pharm Hung; 2005; 75(3):147-59. PubMed ID: 16318239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Structure-activity relationships of analgesics].
    Perlia X
    Methods Find Exp Clin Pharmacol; 1982; 4(7):443-4. PubMed ID: 6302415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES.
    FREE SM; WILSON JW
    J Med Chem; 1964 Jul; 7():395-9. PubMed ID: 14221113
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis and vasodilator activity of new piperazine derivatives.
    Regnier GL; Canevari RJ; Laubie MJ; Le Douarec JC
    J Med Chem; 1968 Nov; 11(6):1151-5. PubMed ID: 5680028
    [No Abstract]   [Full Text] [Related]  

  • 39. Perspectives in the chemistry of narcotic antagonists.
    Jacobson AE; May EL
    Adv Biochem Psychopharmacol; 1973; 8(0):187-9. PubMed ID: 4795005
    [No Abstract]   [Full Text] [Related]  

  • 40. COMPOUNDS POSSESSING MORPHINE-ANTAGONIZING OR POWERFUL ANALGESIC PROPERTIES.
    BENTLEY KW; BOURA AL; FITZGERALD AE; HARDY DG; MCCOUBREY A; AIKMAN ML; LISTER RE
    Nature; 1965 Apr; 206():102-3. PubMed ID: 14334338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.